Suchergebnisse - "Ahn, Jin Seok"

PubPharm (664)

1

Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer

enthalten in: bioRxiv.org | 2024

von Kim, N. | Park, S. | Jo, A. | +18

2

Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancer

enthalten in: EBioMedicine | 2024

von Park, S. | Hong, T. | Hwang, S. | +17

3

Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer

enthalten in: The New England journal of medicine | 2024

von Wu, Y. | Dziadziuszko, R. | Ahn, J. | +120

4

Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Park, S. | Kim, T. | Han, J. | +21

5

Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune-related hepatitis in non-small cell lung cancer patients with chronic hepatitis B

enthalten in: Cancer | 2024

von Hong, J. | Lee, J. | Park, S. | +6

6

Emulating trial to evaluate the effectiveness of routine supportive care on mortality among cancer patients experiencing distress at the time of diagnosis

enthalten in: Journal of affective disorders | 2024

von Kang, D. | Kim, N. | Kim, H. | +6

7

Predicting disease recurrence in limited disease small cell lung cancer using cell-free DNA-based mutation and fragmentome analyses

enthalten in: Translational lung cancer research | 2024

von Park, S. | Kang, J. | Lee, N. | +10

8

Biomarker-driven phase 2 umbrella trial : Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer

enthalten in: Cancer | 2024

von Park, S. | Kim, Y. | Min, Y. | +11

9

A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15)

enthalten in: Therapeutic advances in medical oncology | 2024

von Baek, S. | Jeong, J. | Jung, K. | +25

10

First-Line Alectinib vs. Brigatinib in Advanced Non-Small Cell Lung Cancer with ALK Rearrangement : Real-World Data

enthalten in: Cancer research and treatment | 2024

von Jeon, Y. | Park, S. | Jung, H. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[67]